Literature DB >> 1376561

Mutated c-Ha-ras oncogene alters cytokeratin expression in the human breast epithelial cell line MCF-10A.

T M Paine1, G Fontanini, F Basolo, I Geronimo, J W Elliott, J Russo.   

Abstract

MCF-10A, a spontaneously immortalized human breast epithelial cell line, has been transformed by transfection with the mutated c-Ha-ras oncogene obtained from T24 carcinoma cells. The pattern of cytokeratin expression was studied in MCF-10A cells in comparison with plasmid transfected or MCF-10Aneo cells, normal ras proto oncogene transfected or MCF-10AneoN cells, and transformed or MCF-10AneoT cells. Cytokeratin expression was studied by western immunoblot of total cellular proteins separated by two-dimensional gel electrophoresis. Blots with cytokeratin specific AE1 and AE3 antibodies showed identical molecular weight species of cytokeratins in MCF-10A, MCF-10Aneo, MCF-10AneoN, and MCF-10AneoT cells; however, in MCF-10AneoT cells, the intensity of immunostaining and the number of immunoreactive phosphorylated polypeptides keratins 7, 8, 15, and 16 was decreased. It was concluded that c-Ha-ras oncogene-induced transformation alters quantitatively the cytokeratin pattern of human breast epithelial cells and that these changes could explain some of the morphologic alterations observed in c-Ha-ras transformed cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376561      PMCID: PMC1886550     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Transformation of human breast epithelial cells by c-Ha-ras oncogene.

Authors:  F Basolo; J Elliott; L Tait; X Q Chen; T Maloney; I H Russo; R Pauley; S Momiki; J Caamano; A J Klein-Szanto
Journal:  Mol Carcinog       Date:  1991       Impact factor: 4.784

Review 2.  The molecular biology of intermediate filaments.

Authors:  P M Steinert; A C Steven; D R Roop
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

3.  Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

Authors:  H D Soule; T M Maloney; S R Wolman; W D Peterson; R Brenz; C M McGrath; J Russo; R J Pauley; R F Jones; S C Brooks
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

4.  Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells.

Authors:  R B Nagle; W Böcker; J R Davis; H W Heid; M Kaufmann; D O Lucas; E D Jarasch
Journal:  J Histochem Cytochem       Date:  1986-07       Impact factor: 2.479

5.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

6.  A keratin epitope that is exposed in a subpopulation of preneoplastic and neoplastic mouse mammary epithelial cells but not in normal cells.

Authors:  B B Asch; H L Asch
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

7.  Autophosphorylation of v-Ha-ras p21 is modulated by amino acid residue 12.

Authors:  J B Gibbs; R W Ellis; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

8.  Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins.

Authors:  E D Jarasch; R B Nagle; M Kaufmann; C Maurer; W J Böcker
Journal:  Hum Pathol       Date:  1988-03       Impact factor: 3.466

Review 9.  When is a centromere not a kinetochore?

Authors:  W C Earnshaw
Journal:  J Cell Sci       Date:  1991-05       Impact factor: 5.285

10.  Transfection of human breast epithelial cells with foreign DNA using different transfecting techniques.

Authors:  F Basolo; J Elliott; J Russo
Journal:  Tumori       Date:  1990-10-31
View more
  1 in total

1.  Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins.

Authors:  B Franzén; S Linder; A A Alaiya; E Eriksson; K Uruy; T Hirano; K Okuzawa; G Auer
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.